Clinical Trial Update: Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluates decitabine in combination with the FLAG-Ida chemotherapy regimen and total-body irradiation, followed by donor stem cell transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia
• Undifferentiated Leukemia

Drugs mentioned

• Cytarabine (Ara-C) (cytarabine)
• Decitabine (Dacogen) (decitabine)
• Fludarabine (Fludarabine)
• Idarubicin (idarubicin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia, Acute Undifferentiated Leukemia | Phase 1, Phase 2 | Status: RECRUITING